Vericel Corp. Stock
Price
Target price
?
?
-1.490%
-0.6
-1.490%
-
09:32 / Stuttgart Stock Exchange
WKN: A12FU4 / Symbol: ASTM / Name: Vericel / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Vericel Corp. Stock
We can see a decrease in the price for Vericel Corp.. Compared to yesterday it has lost -€0.600 (-1.490%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Vericel Corp. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Vericel Corp. in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Vericel Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vericel Corp. | -1.490% | 0.000% | 16.185% | 34.000% | 27.215% | 15.517% | -9.865% |
| Pacira Pharmaceuticals | 0.890% | -0.917% | 12.500% | 14.894% | 0.000% | -34.146% | -55.738% |
| Supernus Pharmaceuticals | -0.480% | 1.471% | 7.254% | 46.809% | -3.721% | 51.095% | 78.448% |
| Collegium Pharmaceutical Inc | -1.270% | 0.654% | 6.207% | 18.462% | -25.604% | 54.000% | 43.925% |
Comments
News
Vericel Stock Is Up 10%. Here's What This $402,000 Insider Sale Really Suggests
Michael Halpin, Chief Operating Officer of Vericel Corporation (NASDAQ:VCEL), reported the sale of 10,000 shares of Common Stock for a transaction value of approximately $402,000 on June 18, 2026
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More
Soleus Capital Management disclosed a significant buy of Vericel (NASDAQ:VCEL), adding 1,785,079 shares in the first quarter—an estimated $63.40 million trade based on quarterly average
Vericel Q1 Earnings Call Highlights
Vericel (NASDAQ:VCEL) reported record first-quarter revenue and raised its full-year 2026 outlook, citing strong growth across its MACI cartilage
